Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesafem (Brisdelle) for Menopausal Vasomotor Symptoms
NCT00786188Phase 2Completed
- Sponsor
- Noven Therapeutics, LLC
- Start
- Nov 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paroxetine in vasomotor symptoms, sponsored by Noven Therapeutics, LLC. Started Nov 2008; status: completed.
02
Drugs
paroxetine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00786188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00786188.